Discovery of ML351, a Potent and Selective Inhibitor of Human 15-Lipoxygenase-1
Affiliations
- 1. National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD
- 2. Department of Chemistry and Biochemistry, University of California, Santa Cruz, CA
- 3. Neuroprotection Research Laboratory, Massachusetts General Hospital, Charlestown, MA
PMID: 24672829
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Lipoxygenase